Founding Year
December, 2015
Headquarters
Tokyo, Japan
Management
Shiro Akinaga, Ph.D., CEO
Keiko Hattori, Director
Core Technologies
Drug Delivery Platforms for siRNA, ASO miRNA, mRNA and CRISPR-CAS
Capitalization
Paid-in Capital $ 4.2 million
(As of Jan. 2020)
Investor
Fast Track Initiative, Inc.
UTokyo Innovation Platform Co., Ltd.
SMBC Venture Capital Co., Ltd.
NanoCarrier Co., Ltd.
Locations
Bunkyo-ku, Tokyo, Japan
Kawasaki, Kanagawa, Japan
Academic Partners
